Brief: Shuttle Pharmaceuticals Completes Manufacturing Of Active Pharmaceutical Ingredient For Use In Clinical Trial

Shuttle Pharmaceuticals Holdings

03/08/2023 14:01

Aug 3 (Reuters) - Shuttle Pharmaceuticals Holdings Inc
 SHPH.O :
    * SHUTTLE PHARMACEUTICALS COMPLETES MANUFACTURING OF ACTIVE
PHARMACEUTICAL INGREDIENT (API) FOR USE IN CLINICAL TRIAL
    * SHUTTLE PHARMACEUTICALS HOLDINGS INC - IT REMAINS ON TRACK
TO
COMMENCE ITS PHASE II CLINICAL STUDY IN Q4 OF 2023

Source text for Eikon:  ID:nPn7BrJGQa 
Further company coverage:  SHPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))